AtriCure, Inc. 10-Q filing
Filed 2026-07-27 · Report date 2026-06-30 · 2026
Filing metadata
- Accession number
- 0001323885-26-000035
- Form type
- 10-Q
- CIK
- 0001323885
- Primary document
- https://www.sec.gov/Archives/edgar/data/1323885/000132388526000035/atrc-20260630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AtriCure, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $294.9M | - | - |
| Cost Of Revenue | $66.9M | - | - |
| Gross Profit | $227.9M | - | - |
| Operating Income | $10.2M | - | - |
| Net Income | $9.1M | - | - |
| Eps Basic | 0.19 | - | - |
| Eps Diluted | 0.18 | - | - |
| Cash And Equivalents | $167.8M | - | - |
| Total Assets | $676.6M | - | - |
| Total Liabilities | $160.2M | - | - |
| Shareholders Equity | $516.4M | - | - |
| Operating Cash Flow | $18.2M | - | - |
| Capital Expenditures | $7.6M | - | - |